IMMUCELL CORP /DE/
ICCCUS売上高
$28M
百万USD
営業利益
$2M
百万USD
純利益
$-1M
百万USD
ROE
-3.8%
最新FY
EPS
$-0.12
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-0M | $-0.06 |
| FY2021 | Q2 | - | $0M | $0.02 |
| FY2021 | Q3 | - | $0M | $0.02 |
| FY2021 | FY | - | $-0M | $-0.01 |
| FY2022 | Q1 | - | $1M | $0.07 |
| FY2022 | Q2 | - | $-1M | $-0.09 |
| FY2022 | Q3 | $5M | $-1M | $-0.08 |
| FY2022 | FY | - | $-2M | $-0.32 |
| FY2023 | Q1 | - | $-2M | $-0.30 |
| FY2023 | Q2 | - | $-1M | $-0.18 |
| FY2023 | Q3 | $5M | $-1M | $-0.12 |
| FY2023 | FY | $17M | $-6M | $-0.75 |
| FY2024 | Q1 | - | $-0M | $-0.06 |
| FY2024 | Q2 | - | $-2M | $-0.20 |
| FY2024 | Q3 | - | $-1M | $-0.09 |
| FY2024 | FY | - | $-2M | $-0.26 |
| FY2025 | Q1 | - | $1M | $0.16 |
| FY2025 | Q2 | - | $1M | $0.06 |
| FY2025 | Q3 | $6M | $-0M | $-0.02 |
| FY2025 | FY | $28M | $-1M | $-0.12 |
| FY2026 | Q1 | $10M | $2M | $0.21 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | - | - | - | - | - | $17M | - | $28M |
| 営業利益 | $1M | $-0M | $-1M | $-1M | $-1M | $0M | $-2M | $-6M | $-2M | $2M |
| 純利益 | $1M | $-0M | $-2M | $-1M | $-1M | $-0M | $-2M | $-6M | $-2M | $-1M |
| 総資産 | $25M | $34M | $33M | $39M | $40M | $44M | $45M | $44M | $45M | $43M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $20M | $24M | $22M | $29M | $28M | $33M | $30M | $25M | $28M | $27M |
| 営業CF | $-0M | $1M | $-0M | $0M | $1M | $1M | $-2M | $-5M | $0M | $2M |
| EPS | $0.12 | $-0.03 | $-0.42 | $-0.19 | $-0.14 | $-0.01 | $-0.32 | $-0.75 | $-0.26 | $-0.12 |
| BPS | $4.07 | $4.31 | $3.90 | $4.02 | $3.91 | $4.21 | $3.92 | $3.22 | $3.06 | $2.99 |
| ROE | 2.6% | -0.7% | -10.7% | -4.5% | -3.6% | -0.2% | -8.2% | -23.1% | -7.8% | -3.8% |